Age related macular degeneration (AMD) is a serious threat to public health as it    is the leading cause of visual loss, and its prevalence is predicted to rise considerably.   While current treatment options exist for advanced stages, there is a compelling need to explore preventative and management strategies. This review investigates the potential of nutraceuticals in mitigating AMD progression. We explore the proposed mechanisms   of action by which specific nutraceuticals may counteract oxidative stress, inflammation, and other detrimental factors. The Age Related Eye Disease Study (AREDS) and AREDS2 are two important clinical research studies that are looked at to show how certain formulations with antioxidants and minerals can help people. Furthermore, we delve into emerging evidence on the potential of promising This review underscores the potential of nutraceuticals as a complementary approach for managing AMD, emphasising the  need for further research to optimise their efficacy and personalise treatment plans for  individual patients.